Scientific publisher Nature Publishing Group (NPG), UK, has announced that the Emerging Microbes and Infections (EMI) journal is currently inviting submissions. The new online-only, peer-reviewed open access journal is expected to publish its first articles in July 2012 on nature.com. Submissions can be made via links at www.nature.com/emi.

EMI will report important discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.

Founding Co-Editors-in-Chief Prof. Yumei Wen (Fudan University, Shanghai, China) and Prof. Hans-Dieter Klenk (Philipps-Universität Marburg, Germany) are supported by an 86-member international editorial board.

All articles published in EMI will be open access, on payment of an article processing charge (APC). Authors will have a choice of two non-commercial Creative Commons (CC) licenses. The journal is the 13th journal published by NPG in the Asia-Pacific region, and joins more than 50 journals among NPG's academic and society journal portfolio that are open access or offer open access options.

Search for more Infectious Diseases related scientific journals

Academic publisher Oxford University Press (OUP), UK, will partner with the Pediatric Infectious Diseases Society (PIDS) to publish the Journal of the Pediatric Infectious Diseases Society (JPIDS). The journal will be edited by Dr. Theoklis E. Zaoutis, Associate Professor of Pediatrics at the Children's Hospital of Philadelphia.

A quarterly publication, JPIDS will be dedicated to perinatal, childhood, and adolescent infectious diseases. The journal will publish original research articles, clinical trial reports, guidelines, and topical reviews.

The title will further strengthen OUP's publishing programme in the area of infectious diseases, dedicating particular attention to the interests and needs of the pediatric infectious diseases community.

JPIDS will publish its first print and online issue in March 2012. All members of PIDS will receive an online and print subscription to JPIDS as part of their membership. There will be an option for subscribers to purchase it with the Infectious Diseases Society of America journals, Journal of Infectious Diseases and Clinical Infectious Diseases, which also are published by OUP.

Search for more academic journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.

Medical publisher Mary Ann Liebert, Inc., US, has announced the launch of a bimonthly open access peer-reviewed journal, Shingles and PHN. Scheduled for launch in fall 2011, the journal will provide a much-needed authoritative source and central forum on research and clinical applications.

There are reportedly over 1 million new cases of shingles each year in the US alone. An outbreak of shingles is often followed by a disabling condition known as postherpetic neuralgia (PHN), which is difficult to treat and can have serious consequences. More than 1 in 3 people in the U.S. will develop shingles in their lifetime. Shingles is a painful skin rash caused by the varicella zoster virus, the same virus that causes chickenpox.

Shingles and PHN will explore all aspects of shingles and PHN, including studies of the virus; what causes the virus to reactivate; its actions on the human body; effective pharmacologic and nonpharmacologic acute treatment of shingles and long-term management of PHN; benefits and contraindications of the shingles vaccine; and implications for insurers and policymakers. The journal will include a broad range of scientific research and clinical studies with an impact across many fields including virology, epidemiology, infectious disease, neurology, dermatology, primary care, and policymakers to address this common and disabling condition.

The journal is under the editorial leadership of Dr. Barbara P. Yawn, Director of Research, Olmsted Medical Center, and Adjunct Professor, Family and Community Health, University of Minnesota. Dr. Yawn's research has provided some of the largest group of community-based shingles cases for which diagnosis has been confirmed by medical record review, and shingles complications have been explored.

Search for more Infectious Diseases related medical journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.

Open access publisher BioMed Central, UK, has announced that its journal BMC Research Notes has launched a new topical series on HIV/AIDS and opportunistic diseases and co-infections.

The series, edited by Prof Subhash Parija of the Jawaharlal Institute of Postgraduate Medical Education & Research, India, presents a compilation of studies covering all aspects of HIV and known opportunistic malignancies and co-infections associated with HIV/AIDS. The objective of this series is to encourage scientists and public health experts to share, in a rapid and barrier-free way, information that could help the scientific and medical communities whose goal is to reduce the burden of populations affected by the HIV.

BMC Research Notes publishes scientifically sound research across all fields of biology and medicine. The aim of the journal is to reduce the loss suffered by the research community when results remain unpublished because they do not form a sufficiently complete story to justify the publication of a full research article. A key objective of the journal is to ensure that associated data sets are published in standard, reusable formats whenever possible.

Search for more Infectious Diseases related STM books/journals

STM publisher Elsevier, Netherlands, and the Faculty of Travel Medicine of the Royal College of Physicians and Surgeons of Glasgow (RCPSG) has announced that Travel Medicine and Infectious Disease has been chosen to become the official journal of RCPSG’s Faculty of Travel Medicine.

Launched in 2003, Travel Medicine and Infectious Disease publishes original papers and invites reviews covering all aspects of travel medicine and infectious disease. These include the epidemiology and surveillance of travel-related infectious disease, vaccine-preventable disease, illness in returning travelers, aviation medicine including psychological aspects, environmental hazards of travel, practical clinical issues for travelers, tropical medicine and tropical skin disease and general aspects of travel medicine and infectious disease.

The journal brings together knowledge from different specialties involved in the research and clinical practice of travel medicine and infectious disease.

Search for more Infectious Diseases related STM books/journals

Publisher Lippincott Williams & Wilkins (LWW), US, and the National Foundation of Infectious Disease (NFID) have announced a new publishing partnership. The NFID is a non-profit, tax-exempt organisation dedicated to educating the public and healthcare professionals about the causes, treatment and prevention of infectious diseases.

Under the new agreement, LWW will publish NFID's quarterly newsletter, The Double Helix, as part of the online version of Infectious Disease in Clinical Practice. LWW will also publish Clinical Updates in Infectious Diseases, NFID's continuing medical education monograph series, in both print and online.

Beginning in April 2010, Infectious Diseases in Clinical Practice (IDCP) will become affiliated with NFID. Subscribers of IDCP receive each bimonthly issue as well as online access to the full contents of each issue plus online only pages at the journal website, www.infectdis.com.

Under the editorial leadership of Dr. Thomas M. File, Infectious Diseases in Clinical Practice is geared toward providing clinicians with clinically oriented information that will affect their daily practice. Each bimonthly issue offers original research, reviews, editorials and case reports covering timely clinical topics. Other features include ‘Images in ID-What's the Diagnosis?’ and Clinical Guidelines.

Search for more Infectious Diseases related books/journals

STM publisher Elsevier, Netherlands, has released a special issue of the journal Antiviral Research, marking the 25th anniversary of antiretroviral drug development.

Guest edited by José Esté from Hospital Germans Trias i Pujol, Barcelona, Spain, and Tomas Cihlar, from Gilead sciences Inc., CA, US, the special issue features a variety of review articles from key players in the field. Introducing this special issue of Antiviral Research, Samuel Broder from the Celera Corporation in Alameda, describes how in the last 25 years, HIV-1 has gone from being an ‘inherently untreatable’ infectious agent to one eminently susceptible to a range of approved therapies. In the late 1980s his group, then at the National Cancer Institute, played a key role in the discovery and development of the first generation of antiretroviral agents.

In 2010, Antiviral Research will celebrate its 30th anniversary by organising an Antivirals Congress from November 7-9, 2010, in Amsterdam. The guest editors and various authors of this special issue will present at the Congress, which is expected to serve as an interface between academics, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals.

Search for more infectious diseases related books/journals

Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA) have announced a new publishing partnership. Under the deal, Oxford Journals will publish the latter’s journals, Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID), beginning January 1, 2011. IDSA's twice monthly publications will join Oxford Journals' medicine collection, which includes complementary titles in the field of infectious diseases, as well as with OUP's clinical book publishing programme.

Clinical Infectious Diseases publishes articles on infectious diseases, microbiology, hospital infections, public health, and HIV/AIDS. In 2009 this journal was named one of the ‘100 Most Influential Journals in Biology and Medicine of the past 100 years’ by the Special Libraries Association.

Founded in 1904, the Journal of Infectious Diseases predates the Society's formation in 1963 and is the premier publication for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms.

Search for more Infectious Diseases related books/journal

Discuss this NEWS

Open access publisher BioMed Central, UK, has announced that Dr. Papa Salif Sow, Professor of Infectious Diseases from the University of Dakar in Senegal, will be the new Co-Editor-in-Chief for Journal of the International AIDS Society (JIAS). He succeeds Dr. Elly Katabira who is stepping down from his position as Co-Editor-in-Chief of JIAS.

Dr Sow has served as Head of the Department of Infectious Diseases since 2002 and is also the President of the African Network of AIDS Physicians in Africa and Coordinator of the Regional Centre for Research and Training at Fann Hospital, Dakar, Senegal. His extensive experience in raising awareness and medical help for HIV/AIDS sufferers in Africa is expected to help raise the journal’s profile and ensure that JIAS continues to publish high-quality articles on important aspects of AIDS research from all areas of the world.

JIAS provides an open access forum for the dissemination of HIV-related research from various disciplines. The journal transferred to BioMed Central in September 2008 and strongly encourages submissions from investigators in low- and middle-income countries.

Search for more such Infectious Diseases related books/journals in K-Store

Discuss this NEWS

STM publisher Elsevier, Netherlands, has announced that its journal Vaccine has released a supplement dedicated to vaccines for biodefence during the ‘Vaccines for Biothreats and Emerging and Neglected Diseases Symposium’ in Galveston, Texas, USA. It seeks to provide a comprehensive overview on vaccines that have been developed against a diverse group of human and veterinary pathogens, including Bacillus anthracis, smallpox and blue tongue.

The supplement was launched at the third in a series of symposia around the theme of ‘The Changing Landscape of Vaccine Development’. The symposia were organised by the Sealy Center for Vaccine Development at the University of Texas Medical Branch in conjunction with the James W. McLaughlin Fellowship Fund. The supplement is edited by Alan Barrett of the University of Texas Medial Branch; Shan Lu of the University of Massachusetts; and Greg Poland of the Mayo Clinic Vaccine Research Group.

Biodefense has traditionally been associated with defence against biological warfare agents with an emphasis on military applications. As research continues to develop biodefence countermeasures, vaccines are seen as a critical component of the portfolio to control biothreats.

Vaccine is positioned as an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic research through to applications, safety and legislation.

Search for more such STM publishing books/journals in K-Store

Discuss this NEWS